@article{oai:repo.qst.go.jp:00046779,
 author = {Ito, Kengo and Mori, Etsuo and Fukuyama, Hidenao and Ishii, Kazunari and Washimi, Yukihiko and Asada, Takashi and Mori, Satoru and Meguro, Kenichi and Kitamura, Shin and Hanyu, Haruo and Nakano, Seigo and Matsuda, Hiroshi and Kuwabara, Yasuo and Hashikawa, Kazuo and Momose, Toshimitsu and Uchida, Yoshitaka and Hatazawa, Jun and Minoshima, Satoshi and Kosaka, Kenji and Yamada, Tetsuo and Yonekura, Yoshiharu and 米倉 義晴},
 issue = {10},
 journal = {Annals of Nuclear Medicine},
 month = {Dec},
 note = {Objective
The multicenter prospective cohort study (Japan Cooperative SPECT Study on Assessment of Mild Impairment of Cognitive Function: J-COSMIC) aimed to examine the value of 123I-N-isopropyl-4-iodoamphetamine cerebral blood flow (IMP-CBF) SPECT in regards to early diagnosis of Alzheimer’s disease (AD) in patients with mild cognitive impairment (MCI).},
 pages = {898--906},
 title = {Prediction of outcomes in MCI with 123I-IMP-CBF SPECT:a multicenter prospective cohort study},
 volume = {27},
 year = {2013}
}